A detailed history of Morgan Stanley transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Morgan Stanley holds 1,048,132 shares of ADPT stock, worth $4.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,048,132
Previous 516,460 102.95%
Holding current value
$4.92 Million
Previous $1.87 Million 187.11%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.37 - $5.12 $1.79 Million - $2.72 Million
531,672 Added 102.95%
1,048,132 $5.37 Million
Q2 2024

Oct 17, 2024

SELL
$2.34 - $3.96 $357,247 - $604,573
-152,670 Reduced 22.82%
516,460 $1.87 Million
Q2 2024

Aug 14, 2024

SELL
$2.34 - $3.96 $357,247 - $604,573
-152,670 Reduced 22.82%
516,460 $1.87 Million
Q1 2024

Oct 17, 2024

BUY
$2.88 - $4.8 $439,689 - $732,816
152,670 Added 29.56%
669,130 $2.15 Million
Q1 2024

Aug 16, 2024

SELL
$2.88 - $4.8 $791,046 - $1.32 Million
-274,669 Reduced 29.1%
669,130 $2.15 Million
Q1 2024

May 15, 2024

SELL
$2.88 - $4.8 $791,046 - $1.32 Million
-274,669 Reduced 29.1%
669,130 $2.15 Million
Q4 2023

Aug 16, 2024

BUY
$3.46 - $5.33 $1.48 Million - $2.28 Million
427,339 Added 82.74%
943,799 $4.62 Million
Q4 2023

Feb 13, 2024

BUY
$3.46 - $5.33 $1.86 Million - $2.87 Million
539,016 Added 133.16%
943,799 $4.62 Million
Q3 2023

Nov 15, 2023

SELL
$5.07 - $8.44 $1.3 Million - $2.16 Million
-255,730 Reduced 38.72%
404,783 $2.21 Million
Q2 2023

Aug 14, 2023

SELL
$6.19 - $8.78 $330,601 - $468,931
-53,409 Reduced 7.48%
660,513 $4.43 Million
Q1 2023

May 15, 2023

SELL
$7.8 - $10.11 $5.41 Million - $7.01 Million
-693,768 Reduced 49.28%
713,922 $6.3 Million
Q4 2022

Feb 14, 2023

BUY
$6.26 - $9.34 $2.42 Million - $3.61 Million
386,229 Added 37.81%
1,407,690 $10.8 Million
Q3 2022

Nov 14, 2022

SELL
$6.5 - $12.67 $818,382 - $1.6 Million
-125,905 Reduced 10.97%
1,021,461 $7.27 Million
Q2 2022

Oct 27, 2022

BUY
$6.4 - $14.73 $4.1 Million - $9.43 Million
640,112 Added 126.19%
1,147,366 $9.28 Million
Q2 2022

Aug 15, 2022

BUY
$6.4 - $14.73 $4.1 Million - $9.43 Million
640,112 Added 126.19%
1,147,366 $9.28 Million
Q1 2022

Oct 27, 2022

SELL
$10.12 - $28.9 $6.48 Million - $18.5 Million
-640,112 Reduced 55.79%
507,254 $7.04 Million
Q1 2022

May 13, 2022

BUY
$10.12 - $28.9 $1.17 Million - $3.34 Million
115,575 Added 29.51%
507,254 $7.04 Million
Q4 2021

Feb 14, 2022

SELL
$25.17 - $36.85 $1.84 Million - $2.69 Million
-72,950 Reduced 15.7%
391,679 $11 Million
Q3 2021

Nov 15, 2021

BUY
$30.02 - $39.87 $13.9 Million - $18.5 Million
464,629 New
464,629 $15.8 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.